Neurostimulation Systems with Advanced Flexible Circuit Assemblies

Publication ID: 24-11857148_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Neurostimulation Systems with Advanced Flexible Circuit Assemblies,” Published Technical Disclosure No. 24-11857148_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857148_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,148.

Summary of the Inventive Concept

This inventive concept discloses next-generation neurostimulation systems that integrate advanced flexible circuit assemblies with nanoscale materials, 3D-printed substrates, and machine learning algorithms to optimize treatment outcomes for neurological disorders.

Background and Problem Solved

The original patent addressed sympathetic nerve modulation using medical devices with flexible circuit assemblies. However, these devices have limitations in terms of their size, material properties, and ability to adapt to real-time neural activity feedback. The new inventive concept solves these problems by introducing advanced flexible circuit assemblies that enable more precise and personalized neural stimulation.

Detailed Description of the Inventive Concept

The neurostimulation system comprises a neural interface module, a flexible circuit assembly, and a control unit. The flexible circuit assembly integrates a nanoscale material and a 3D-printed substrate, allowing for increased precision and adaptability. The control unit adjusts stimulation parameters based on real-time neural activity feedback from the neural interface module. The system can be implanted or worn externally, and can be powered wirelessly using a power harvesting module. The system's adaptability is further enhanced by machine learning algorithms that optimize treatment outcomes.

Novelty and Inventive Step

The new inventive concept introduces several novel features, including the use of nanoscale materials, 3D-printed substrates, and machine learning algorithms to optimize treatment outcomes. These features provide a significant improvement over the original patent, enabling more precise and personalized neural stimulation.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different nanoscale materials, substrate designs, or machine learning algorithms. Additionally, the system could be adapted for use in other medical applications, such as cardiac rhythm management or neuromuscular therapy.

Potential Commercial Applications and Market

The neurostimulation system has significant commercial potential in the medical device industry, particularly in the areas of neurological disorder treatment and neural modulation. The system's adaptability and precision make it an attractive solution for patients and healthcare providers seeking more effective treatment options.

CPC Classifications

SectionClassGroup
A A61 A61B18/1492
A A61 A61F7/007
A A61 A61F7/123
H H05 H05K1/028
A A61 A61B2018/0016
A A61 A61B2018/0022
A A61 A61B2018/00404
A A61 A61B2018/00434
A A61 A61B2018/00511
A A61 A61B2018/00577
A A61 A61B2018/00797
A A61 A61B2018/00815
A A61 A61B2018/1465
A A61 A61B2018/1467
A A61 A61B2018/1475
A A61 A61F2007/126

Original Patent Information

Patent NumberUS 11,857,148
TitleMedical devices with flexible circuit assemblies
Assignee(s)Boston Scientific Scimed, Inc.